Jason Hoitt - Chief Patient Officer at Stoke Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Patient Officer
Issuer Symbol
STOK on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jason Hoitt since 05 Jan 2025

Holdings reported by Jason Hoitt for Stoke Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,802 $17,533 $9.73 18 Jun 2025 Direct

There are no transactions reported by Jason Hoitt for Stoke Therapeutics, Inc.